Read Full Article
Nelson Peltz's Trian Management sees governance issues at Chemours as all the more reason to continue fighting its proxy war against DuPont...
We believe it is a shame that Trian is trying to exploit our responsive corporate governance practices for their own self-serving purposes in the context of the proxy contest.
DuPont's current Board and management team have a well-documented record of taking decisive action since 2009 and continue to execute on a transformative strategy that has delivered clear results, many of which were initiated or executed long before Trian's investment. This strategy has delivered results.